Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP19102.RAeZUFgrx15qa1TGg-hwvN36-V_jhrSXpS0J48mLqY6yM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP19102.RAeZUFgrx15qa1TGg-hwvN36-V_jhrSXpS0J48mLqY6yM130_assertion type Assertion NP19102.RAeZUFgrx15qa1TGg-hwvN36-V_jhrSXpS0J48mLqY6yM130_head.
- NP19102.RAeZUFgrx15qa1TGg-hwvN36-V_jhrSXpS0J48mLqY6yM130_assertion description "[Consolidation biochemotherapy for patients with advanced nonsmall cell lung carcinoma responding to induction PVM (cisplatin, vinblastine, mitomycin-C) regimen. A phase II study.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP19102.RAeZUFgrx15qa1TGg-hwvN36-V_jhrSXpS0J48mLqY6yM130_provenance.
- NP19102.RAeZUFgrx15qa1TGg-hwvN36-V_jhrSXpS0J48mLqY6yM130_assertion evidence source_evidence_curated NP19102.RAeZUFgrx15qa1TGg-hwvN36-V_jhrSXpS0J48mLqY6yM130_provenance.
- NP19102.RAeZUFgrx15qa1TGg-hwvN36-V_jhrSXpS0J48mLqY6yM130_assertion SIO_000772 8635092 NP19102.RAeZUFgrx15qa1TGg-hwvN36-V_jhrSXpS0J48mLqY6yM130_provenance.
- NP19102.RAeZUFgrx15qa1TGg-hwvN36-V_jhrSXpS0J48mLqY6yM130_assertion wasDerivedFrom ctd_human-20150221 NP19102.RAeZUFgrx15qa1TGg-hwvN36-V_jhrSXpS0J48mLqY6yM130_provenance.
- NP19102.RAeZUFgrx15qa1TGg-hwvN36-V_jhrSXpS0J48mLqY6yM130_assertion wasGeneratedBy ECO_0000218 NP19102.RAeZUFgrx15qa1TGg-hwvN36-V_jhrSXpS0J48mLqY6yM130_provenance.